ArticleBMJ open2021
Published models that predict hospital readmission: a critical appraisal.
Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Applicability of predictive models for 30-day unplanned hospital readmission risk in paediatrics: a systematic review.BMJ open · 2022Pooled it
- Patient and Healthcare Provider Priorities for Risk Prediction of Hospital Readmission: A Nominal Group Technique Consensus Study.Journal of general internal medicine · 2026Article
- Risk of Hospital Readmission among People with CKD: A Population-Based Cohort Study.Clinical journal of the American Society of Nephrology : CJASN · 2026Article
- The SUPREME Index for 30-day all-cause readmission: development and internal validation of a machine learning-based risk stratification index in community-dwelling adults.BMC medical informatics and decision making · 2026Article
- Article
- Risk-prediction models for intravenous immunoglobulin resistance in Kawasaki disease: Risk-of-Bias Assessment using PROBAST.Pediatric research · 2023Article
- Impact of social determinants of health on improving the LACE index for 30-day unplanned readmission prediction.JAMIA open · 2022Article
- The risk of death or unplanned readmission after discharge from a COVID-19 hospitalization in Alberta and Ontario.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2022Article
- Trust in AI: why we should be designing for APPROPRIATE reliance.Journal of the American Medical Informatics Association : JAMIA · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe number of readmission risk prediction models available has increased rapidly, and these models are used extensively for health decision-making. Unfortunately, readmission models can be subject to flaws in their development and validation, as well as limitations in their clinical usefulness.
objectiveTo critically appraise readmission models in the published literature using Delphi-based recommendations for their development and validation.
methodsWe used the modified Delphi process to create
resultsWe found that published models (n=81) followed 6.8 recommendations (45%) on average. Many models had weaknesses in their development, including failure to internally validate (12%), failure to account for readmission at other institutions (93%), failure to account for missing data (68%), failure to discuss data preprocessing (67%) and failure to state the model's eligibility criteria (33%).
conclusionsThe high prevalence of weaknesses in model development identified in the published literature is concerning, as these weaknesses are known to compromise predictive validity. CAMPR may support researchers, clinicians and administrators to identify and prevent future weaknesses in model development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.